Fenaux P - Search Results

1

A randomized, double-blind, placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia.

Archimbaud E, Ottmann OG, Yin JA, Lechner K, Dombret H, Sanz MA, Heil G, Fenaux P, Brugger W, Barge A, O'Brien-Ewen C, Matcham J, Hoelzer D. Archimbaud E, et al. Among authors: fenaux p. Blood. 1999 Dec 1;94(11):3694-701. Blood. 1999. PMID: 10572081 Free article. Clinical Trial.

2

Intensive sequential chemotherapy with mitoxantrone and continuous infusion etoposide and cytarabine for previously treated acute myelogenous leukemia.

Archimbaud E, Leblond V, Michallet M, Cordonnier C, Fenaux P, Travade P, Dreyfus F, Jaubert J, Devaux Y, Fiere D. Archimbaud E, et al. Among authors: fenaux p. Blood. 1991 May 1;77(9):1894-900. Blood. 1991. PMID: 2018832 Free article.

3

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.

Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, et al. Fenaux P, et al. Blood. 1992 Nov 1;80(9):2176-81. Blood. 1992. PMID: 1421389 Free article. Clinical Trial.

4

All-trans-retinoic acid as a differentiating agent in the treatment of acute promyelocytic leukemia.

Degos L, Dombret H, Chomienne C, Daniel MT, Micléa JM, Chastang C, Castaigne S, Fenaux P. Degos L, et al. Among authors: fenaux p. Blood. 1995 May 15;85(10):2643-53. Blood. 1995. PMID: 7742522 Free article. Review. No abstract available.

5

Timed sequential chemotherapy for previously treated patients with acute myeloid leukemia: long-term follow-up of the etoposide, mitoxantrone, and cytarabine-86 trial.

Archimbaud E, Thomas X, Leblond V, Michallet M, Fenaux P, Cordonnier C, Dreyfus F, Troussard X, Jaubert J, Travade P, et al. Archimbaud E, et al. Among authors: fenaux p. J Clin Oncol. 1995 Jan;13(1):11-8. doi: 10.1200/JCO.1995.13.1.11. J Clin Oncol. 1995. PMID: 7799010

6

[Sequential chemotherapy with or without GM-CSF in acute myeloid leukemia (AML) in the advanced phase: current status of protocols EMA 86 and EMA 91].

Archimbaud E, Leblond V, Fenaux P, Dombret H, Cordonnier C, Cony-Makoul P, Dreyfus F, Troussard X, Auzanneau G, Stoppa AM, et al. Archimbaud E, et al. Among authors: fenaux p. Nouv Rev Fr Hematol (1978). 1994 Jul;36 Suppl 2:S145-8. Nouv Rev Fr Hematol (1978). 1994. PMID: 7971264 French. No abstract available.

7

Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group.

Fenaux P, Wattel E, Archimbaud E, Sanz M, Hecquet B, Fegueux N, Guerci A, Link H, Fey M, Castaigne S, et al. Fenaux P, et al. Blood. 1994 Jul 15;84(2):666-7. Blood. 1994. PMID: 8025292 Free article. No abstract available.

8

Effect of all transretinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. European APL 91 Group.

Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Link H, Guerci A, Duarte M, Daniel MT, Bowen D, et al. Fenaux P, et al. Blood. 1993 Dec 1;82(11):3241-9. Blood. 1993. PMID: 8241496 Free article. Clinical Trial.

9

Granulocyte-macrophage colony-stimulating factor in association to timed-sequential chemotherapy with mitoxantrone, etoposide, and cytarabine for refractory acute myelogenous leukemia.

Archimbaud E, Fenaux P, Reiffers J, Cordonnier C, Leblond V, Travade P, Troussard X, Tilly H, Auzanneau G, Marie JP, et al. Archimbaud E, et al. Among authors: fenaux p. Leukemia. 1993 Mar;7(3):372-7. Leukemia. 1993. PMID: 8445942 Clinical Trial.

10

Timed sequential chemotherapy for advanced acute myeloid leukemia.

Archimbaud E, Leblond V, Fenaux P, Dombret H, Cordonnier C, Dreyfus F, Cony-Makhoul P, Tilly H, Troussard X, Auzanneau G, Thomas X, Ffrench M, Marie JP. Archimbaud E, et al. Among authors: fenaux p. Hematol Cell Ther. 1996 Apr;38(2):161-7. doi: 10.1007/s00282-996-0161-2. Hematol Cell Ther. 1996. PMID: 8931997 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

903 results

Search Page